Novo Nordisk A/S

NYSE (USD): Novo Nordisk A/S (NVO)

Last Price

73.77

Today's Change

-0.24 (0.32%)

Day's Change

72.75 - 74.37

Trading Volume

8,146,003

Overview

Market Cap

329 Billion

Shares Outstanding

4 Billion

Avg Volume

10,196,403

Avg Price (50 Days)

68.26

Avg Price (200 Days)

91.44

PE Ratio

20.38

EPS

3.62

Earnings Announcement

06-Aug-2025

Previous Close

74.01

Open

73.82

Day's Range

72.75 - 74.38

Year Range

57.0 - 148.15

Trading Volume

7,553,861

Price Change Highlight

1 Day Change

-0.32%

5 Day Change

-5.23%

1 Month Change

8.17%

3 Month Change

-4.02%

6 Month Change

-13.21%

Ytd Change

-15.71%

1 Year Change

-48.03%

3 Year Change

36.74%

5 Year Change

117.16%

10 Year Change

157.85%

Max Change

46006.25%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment